Galectin-3 was suggested to be expressed by tumor cells in 84% of samples, and it might have dual functions: weak expression correlated with increased tumor invasion and growth, while positive expression with decreased invasion and growth (36). This evidence concerns the gene LGALS3 and neoplasm.